- £365.25m
- £214.28m
- $44.26m
- 19
- 11
- 83
- 27
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16.7 | 21.6 | 26.2 | 33.9 | 44.3 |
Cost of Revenue | |||||
Gross Profit | 14.8 | 19.1 | 23.4 | 30.2 | 39.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 25.1 | 34 | 37.2 | 52.1 | 71.6 |
Operating Profit | -8.42 | -12.4 | -11.1 | -18.2 | -27.4 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -8.87 | -12.9 | -11.8 | -19.1 | -23.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.87 | -12.9 | -11.8 | -19.1 | -23.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -8.87 | -12.9 | -11.8 | -19.1 | -23.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.87 | -12.9 | -11.8 | -19.1 | -23.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.173 | -0.229 | -0.17 | -0.211 | -0.232 |